THE CANCER GENOMICS CONSORTIUM (CGC) IS COMMITTED TO PROVIDING HIGH QUALITY EDUCATION AND PROMOTING BEST LABORATORY PRACTICES IN CLINICAL CANCER GENOMICS.
Reported officers (all unpaid)
No paid executives reported in 2024. CANCER GENOMICS CONSORTIUM CANCER CYTOGENETICS LABORATORY reported 13 unpaid officers and board members on its 990.
Revenue and expenses over time
CANCER GENOMICS CONSORTIUM CANCER CYTOGENETICS LABORATORY reported revenue and expenses across 2 filing years.
What Medical Research executives earn
CANCER GENOMICS CONSORTIUM CANCER CYTOGENETICS LABORATORY reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $114,840.
These are medical research sector-wide figures, not this organization's reported pay. Based on 283 organizations across 283 filings (2021 – 2023).
See full Medical Research compensation data →Common questions about CANCER GENOMICS CONSORTIUM CANCER CYTOGENETICS LABORATORY
What are CANCER GENOMICS CONSORTIUM CANCER CYTOGENETICS LABORATORY's revenue and expenses?
In 2024, CANCER GENOMICS CONSORTIUM CANCER CYTOGENETICS LABORATORY reported $437k in total revenue and $469k in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.